I

insitro Tech Stack

AI-powered drug discovery platform using causal biology models

Biotechnology Research South San Francisco, California 201–500 employees Founded 2018 Privately Held

insitro combines PyTorch, TensorFlow, and RDKit with infrastructure tools (Airflow, Nextflow, Snakemake, Ray, Spark) to operationalize AI-driven therapeutics discovery. The tech stack reflects a compute-heavy, multi-stage pipeline: feature engineering (Pandas, Polars) feeding into ML training and inference, orchestrated across AWS/GCP/Azure. Hiring skews heavily toward research (7 roles) and data (5 roles) with senior-level fill (9 seniors, 4 directors, 3 VPs), indicating a scaling phase for the core discovery engine.

Tech Stack 19 technologies

Core StackPython PyTorch TensorFlow PostgreSQL MySQL AWS Pandas Apache Airflow Apache Spark CMMS RDKit SQL GCP Azure Polars Nextflow Snakemake Ray Dask

What insitro Is Building

◆Challenges

Lack of disease-relevant cell models
Maintaining lab automation systems
Accelerating drug development process
Disruptive team dynamics
Improving uptime of lab automation
Streamlining support processes
Low drug discovery success rate
Slow preclinical drug development
Bottlenecks in drug discovery pipeline
Inefficient high-throughput screening

▲Active Projects

Establish sops and slas for service
Ml pipelines for iterative learning
Clinical program plans
Clinical data package generation
Implement instrument status dashboards
Develop preventative maintenance schedules
Target validation & conversion
Agentic ai project management tools
Design and validate del synthesis schemes
Implement machine learning approaches in del design

Hiring Activity

Decelerating20 roles · 4 in 30d

Department

Research

7

Data

5

Engineering

5

Healthcare

2

HR

2

Seniority

Senior

9

Director

4

VP

3

Lead

2

Intern

1

Manager

1

Mid

1

Notable leadership hires: Project Team Lead, Head of People

Company intelligence

Find more companies like insitro by tech stack, pain points and active projects

Get started free

About insitro

insitro is a drug discovery platform company founded in 2018 and headquartered in South San Francisco. The company targets neuroscience and metabolic diseases using a proprietary causal AI model trained on integrated human and cellular datasets. The platform enables rapid identification of genetic drivers and AI-assisted medicine design, structured around a self-learning loop where each biology dataset improves predictive accuracy. Operations span research, data engineering, and clinical program planning, with 201–500 employees across the United States. The company is privately held.

HeadquartersSouth San Francisco, California

Company Size201–500 employees

Founded2018

Hiring MarketsUnited States

Frequently Asked Questions

What machine learning frameworks does insitro use?

insitro's ML stack includes PyTorch, TensorFlow, and RDKit for chemistry modeling, with Pandas and Polars for data manipulation. Orchestration runs on Apache Airflow, Nextflow, Snakemake, and Ray, deployed across AWS, GCP, and Azure.

Is insitro hiring research and data roles?

Yes. insitro has 22 active roles, with 7 research and 5 data positions open. Leadership is being hired at senior (9), director (4), and VP (3) levels. All hiring is currently in the United States.

What is insitro working on in AI and drug development?

Active projects include ML pipelines for iterative learning, agentic AI project management tools, clinical program planning, target validation and conversion, and machine learning approaches in DEL synthesis design. Lab operationalization focuses on instrument dashboards and preventative maintenance scheduling.